Similar Posts
Danaher (NYSE:DHR) Issues Quarterly Earnings Results, Beats Expectations By $0.18 EPS
Danaher (NYSE:DHR – Get Free Report) issued its quarterly earnings results on Tuesday. The conglomerate reported $1.89 EPS for the quarter, topping the consensus estimate of $1.71 by $0.18. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The company had revenue of $6.05 billion during the quarter, compared to…
Blog Post: Day 36 of $QQQ short term down-trend; Indexes are very oversold; QQQ topped out in October, 2025, long before the current war, see weekly chart. End of the war may not change the longer term trend. Modified daily Guppy chart would have had you exit META long before Thursday’s debacle, see chart.
The Stage 4 down-trend has yet to begin. That is when I typically exited the markets. However, I did not wait for that this time. I am more of a chicken now. The market could have a final rally up to the 30 week, 4 week or 10 week averages. Prior major tops did that…
Theriva™ Biologics anuncia la designación de vía rápida concedida por la FDA estadounidense al VCN-01 para el tratamiento del cáncer de páncreas metastásico – Bio Tech Winners
May 24, 2024 by Leave a Comment Last Updated on May 24, 2024 by [#item_full_content] Like this: Like Loading… Related Filed Under: biotech news, News Reader Interactions This site uses Akismet to reduce spam. Learn how your comment data is processed. Source link
Disney to cut nearly 6% staff across units, WSJ reports
Disney to cut nearly 6% staff across units, WSJ reports Source link
Q1 GDP Tracking: No Growth
by Calculated Risk on 4/25/2025 10:13:00 AM The advance estimate of Q1 GDP is scheduled to be released on Wednesday, April 30th. The consensus is for a 0.2% increase in real GDP, quarter-over-quarter annualized – or essentially no growth in Q1. From BofA: We expect 1Q advance GDP to print at a weak 0.4% q/q…
LYL – Lycopodium Limited
sorry Prawn, pretty new to this Basically LYL is an engineering consultancy firm based in aus, with offices in the Philippines. they have a market cap of $152m and a P/E ratio of 13.2 on a few occasions i have seen buy recommendations for this stock in various media sources. they have also just announced…